The syntheses of 4-amino-1-(β-D-ribofuranosyl)-1H-1,2,3-triazolo[4,5-c]pyridine (8-aza-3-deazaadenosine, 1), 4-amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)-1H-1,2,3-triazolo[4,5-c]pyridine (2′-deoxy-8-aza-3-deazaadenosine, 2), and their N8 and N7 glycosylated analogues (12,13, 21,22) and 4-amino-1-(2,3-dideoxy-β-D-erythro-pentof uranosyl)-1H-1,2,3-triazolo [4,5-c]pyridine (2′,3′-dideoxy-8-aza-3-deazaadenosine, 3) were carried out by glycosylation of the 4-chloro-3H-1,2,3-triazolo[4,5-c]pyridine anion. The anomeric configuration as well as the position of glycosylation were determined by 1H-, 13C-NMR, UV and N.O.E. difference spectroscopy. Nucleoside (2) and its parent compound 2′-deoxy-3-deazaadenosine were found active against ASFV and VSV. The 4-chloro-2-(β-D-ribofuranosyl)-2H-1,2,3-triazolo[4,5-c] pyridine (9) was active against Coxsackie B1, whereas none of the 8-aza-3-deaza purine nucleosides, compound (3) included, was active against HIV-1. The 6-chloro derivatives of 8-aza-3-deazapurine ribo- and 2′-deoxyribonucleosides (11) and (20) showed some activity against LoVo human colon adenocarcinoma.
References
1.
BodnerA.J.CantoniG.L., and ChiangP.K. (1981) Antiviral activity of 3-deazaadenosine and 5′-deoxy-5′-isobutylthio-3-deazaadenosine (3-deaza-SIBA). Biochem Biophys Res Commun98: 476–481.
2.
CollinsP., and BauerD.J. (1977) Relative potencies of anti-Herpes compounds. Ann NY Acad Sci284: 49–54.
3.
DeaP., and RobinsR.K. (1978) Determination of the site of glycosilation in various nucleosides by Carbon-13 NMR spectroscopy. In: Chemistry and Biology of Nucleosides and Nucleotides.HarmonR.E.RobinsR.K., and TownsendL.B. (eds). New York: Academic Press, pp. 301–310.
4.
FranchettiP.CappellacciL.CristalliG.GrifantiniM.PaniA.La CollaP., and NocentiniG. (1991) Synthesis and evaluation of anti-HIV-1 and antitumor activity of 2′,3′-didehydro-2′,3′-dideoxy-3-deazaadenosine, 2′,3′-dideoxy-3-deazaadenosine and some 2′,3′-dideoxy-3-deazaadenosine 5′-dialkyl phosphates. Nucleoside Nucleotide10 (7): 1551–1562.
5.
FranchettiP.CappellacciL.GrifantiniM.LupidiG.NocentiniG., and BarziA. (1992) 8-Aza analogues of deaza purine nucleosides. Synthesis arid biological evaluation of 8-aza-1-deazaadenosine and 2′-deoxy-8-aza-1-deazaadenosine. Nucleoside Nucleotide11 (5): 1059–1076.
KazimierczukZ.CottamH.B.RevankarG.R., and RobinsR.K. (1984) Synthesis of 2′-deoxytubercidin, 2′-deoxyadenosine, and related 2′-deoxynucleosides via a novel direct stereospe-cific sodium salt glycosylation procedure. J Am Chem Soc106: 6379–6382.
8.
KazimierczukZ.BindingU., and SeelaF. (1989) Synthesis of 8-aza-2′-deoxyadenosine and related 7-amino-3H-1,2,3-triazolo[4,5-d]pyrimidine 2′-deoxyribofuranosides: stereoselective glycosylation via the nucleobase anion. Helv Chim Acta72: 1527–1536.
9.
KellerB.T., and BorchardtR.T. (1988) Inhibition of S-adenosylmethionine-dependent transmethylation as an approach to the development of antiviral agents. In: Antiviral Drug Development.De ClercqE. (ed.). NATO ASI Ser., Vol. 143, NY: Plenun Press, pp. 123–138.
10.
MatthewsR.E.F. (1958) Biosynthetic incorporation of metabolite analogues. Pharmacol Rev10: 359–406.
11.
MayJ.A.Jr, and TownsendL.B. (1976) Synthesis of v-triazolo[4,5-c]pyridine nucleosides and 4-(β-D-ribofuranosyl)amino-1,2,3-thiadiazolo[4,5-b]pyridine via a rearrangement. J Org Chem41: 1449–1456.
12.
MillerR.L.AdamczykD.L.MillerW.H.KoszalkaG.W.RideoutJ.L.BeachamL.M.ChaoE.Y.HaggertyJ.J.KrenitskyT.A., and ElionG.B. (1979) Adenosine kinase from rabbit liver. II. Substrate and inhibitor specificity. J Biol Chem254: 2346–2352.
13.
MontgomeryJ.A. (1970) Biochemical basis for the drug actions of purines. Prog Med Chem7: 69–123.
14.
MontgomeryJ.A.ElliotR.D., and ThomasH.J. (1975) The synthesis and the evaluation of azapurine nucleosides as cytotoxic agents. Ann NY Acad Sci255: 292–304.
15.
PauwelsR.BalzariniJ.BabaM.SnoeckR.ScholsD.HerdewijnP.DesmyterJ., and De ClercqE. (1988) Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J Virol Methods20: 309–321.
16.
PughC.S.G.BorchardtR.T., and StoneH.O. (1977) Inhibition of Newcastle disease virion messenger RNA(guanine-7-)-methyl-transferase by analogues of S-adenosylhomocysteine. Biochemistry16: 3928–3932.
17.
RevankarG.R., and RobinsR.K. (1991) The synthesis and chemistry of heterocyclic analogues of purine nucleosides and nucleotides. In: Chemistry of nucleosides and nucleotides.TownsendL.B. (ed.). New York: Plenum Press, Vol. 2, pp. 161–398.
18.
RobinsR.K., and RevankarG.R. (1988) Design of nucleoside analogs as potential antiviral agents. In: Antiviral Drug Development.De ClercqE. (ed.). NATO ASI Ser. Vol. 143, pp. 11–36.
19.
RosemeyerH.TothG., and SeelaF. (1989) Assignment of anomeric configuration of D-ribo-, arabino-, 2′-deoxyribo-, and 2′,3′-dideoxyribonucleosides by N.O.E. difference spectroscopy. Nucleoside Nucleotide8(4): 587–597.
20.
ScudieroD.A.ShoemakerR.B.PauliK.D.MonksA.TierneyS.NofzigerT.H.CurrensM.J.SeniffD., and BoydM.R. (1988) Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res48: 4827–4833.
21.
SeelaF.MuthH.P., and RolingA. (1991) Synthesis of pyrrolo[2,3-d]pyrimidine 2′,3′-dideoxyribonucleosides related to 2′,3′-dideoxyadenosine and 2′,3′-dideoxyguanosine and inhibitory activity of 5′-triphosphates on HIV-1 reverse transcriptase. Helv Chim Acta74: 554–564.
22.
StevensJ.B.NessR.K., and FletcherH.G.Jr, (1968) Syntheses with partially benzylated sugar. XI. Studies on the synthesis of the anomeric 5,6-dimethyl-1-D-ribofuranosylbenzimidazoles (ribazoles). Comparison of the condensation of 2,3,5-tri-O-benzoyl-D-ribofuranosyl bromide and 2,3,5-tri-O-benzyl-D-ribofuranosyl chloride with 5,6-dimethylbenzimidazole. J Org Chem33: 1806–1810.
23.
TalikZ., and PlazekE. (1956) The nitration of 2-chloro-4-amino-pyridine. Roczniki Chem30: 1139–1149.
